Old Web
English
Sign In
Acemap
>
Paper
>
Safety and long-term efficacy of AAV2-BEST1 gene augmentation therapy in canine model of Best vitelliform macular dystrophies
Safety and long-term efficacy of AAV2-BEST1 gene augmentation therapy in canine model of Best vitelliform macular dystrophies
2019
Karina E. Guziewicz
Artur V. Cideciyan
Brian T. Kendrick
Valerie L. Dufour
Gordon Ruthel
András M. Komáromy
Simone Iwabe
William W. Hauswirth
William A. Beltran
Samuel G. Jacobson
Gustavo D. Aguirre
Keywords:
Internal medicine
BEST1 gene
Term (time)
Oncology
canine model
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]